4//SEC Filing
Dahlbeck Scott 4
Accession 0001104659-22-064646
CIK 0001792581other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 4:15 PM ET
Size
7.0 KB
Accession
0001104659-22-064646
Insider Transaction Report
Form 4
Dahlbeck Scott
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2022-05-23+17,240→ 446,757 total - Exercise/Conversion
Restricted Stock Units
2022-05-23−17,240→ 0 total→ Common Stock (17,240 underlying)
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On August 20, 2020, the reporting person was granted 17,420 restricted stock units, vesting on October 16, 2021.
Documents
Issuer
Kiromic Biopharma, Inc.
CIK 0001792581
Entity typeother
Related Parties
1- filerCIK 0001815317
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 4:15 PM ET
- Size
- 7.0 KB